OptimizeRx Corporation (OPRX)

Market Cap	233.04M
Revenue (ttm)	94.37M
Net Income (ttm)	-15.41M
Shares Out	18.50M
EPS (ttm)	-0.84
PE Ratio	n/a
Forward PE	24.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,409
Open	13.15
Previous Close	13.28
Day's Range	12.67 - 13.37
52-Week Range	3.78 - 15.71
Beta	1.34
Analysts	Buy
Price Target	10.81 (-14.21%)
Earnings Date	Aug 7, 2025

About OPRX

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2006
• Employees: 129
• Stock Exchange: NASDAQ
• Ticker Symbol: OPRX
• Website: https://www.optimizerx.com

Financial Performance

In 2024, OptimizeRx's revenue was $92.13 million, an increase of 28.81% compared to the previous year's $71.52 million. Losses were -$20.11 million, 14.5% more than in 2023.

Analyst Summary

According to 8 analysts, the average rating for OPRX stock is "Buy." The 12-month stock price target is $10.81, which is a decrease of -14.21% from the latest price.

Price Target

$10.81

(-14.21% downside)

Analyst Consensus: Buy